Latest filing published 12 Aug 2016 for Anterix Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -34.0%Entry US$32.89 · Close at T+365 US$21.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew Daskalakis: trading record in brief
This profile gathers the share dealings of Andrew Daskalakis in Anterix Inc. Between 14 September 2015 and 10 August 2016, the trades on record add up to 3 filings.
The open-market record is one-sided, with 1 purchase worth €84k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.
The record was last updated on 12 August 2016 with a share grant in Anterix Inc. The clock since the last published purchase (16 September 2015) now reads 4,072 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Daskalakis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,107 shares0Common StockSEC:0001209191-16-136869:0
- 2,282 shares0Common StockSEC:0001209191-15-078975:0
- 3,000 shares@ US$31.75Common StockSEC:0001209191-15-070994:0Canonical exit: 13 Dec 2015 (T+90)
3 of 3 declarations
